Also trades as: CSNVY (OTC) · $vol 0M · CSNVF (OTC) · $vol 0M

€21.60 ($24.14)

-0.58 (-2.61%)

Weekly Expected Move ±3.7%

€20 €21 €22 €22 €23

AMS · Basic Materials · Chemicals - Specialty · Tech Score Neutral · Power 56 · €1.2B mcap · 52M float · 0.236% daily turnover

Revenue

$1.3B -1.6% ▼

5Y CAGR: +5.1%

Gross Profit

$330M +5.8% ▲

5Y CAGR: +4.1%

Operating Income

$116M +50.7% ▲

5Y CAGR: +2.3%

Net Income

$75M -61.1% ▼

5Y CAGR: +0.5%

EPS (Diluted)

$1.29 -60.2% ▼

5Y CAGR: +1.0%

EBITDA

$202M +17.6% ▲

5Y CAGR: +5.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.1B	$1.5B	$1.4B	$1.3B	$1.3B
YoY Growth	+8.5%	+36.2%	-1.0%	-10.8%	-1.6%
Cost of Revenue	$805M	$1.1B	$959M	$976M	$937M
Gross Profit	$266M	$324M	$305M	$312M	$330M
Gross Margin	24.8%	22.2%	21.2%	24.2%	26.1%
R&D Expenses	$66M	$47M	$46M	$48M	$43M
SG&A Expenses	$153M	$174M	$176M	$188M	$171M
Operating Expenses	$194M	$221M	$228M	$235M	$214M
Operating Income	$82M	$111M	$77M	$77M	$116M
Operating Margin	7.7%	7.6%	5.4%	6.0%	9.2%
Interest Expense	$12M	$16M	$35M	$23M	$22M
Income Before Tax	$86M	$116M	$85M	$62M	$95M
Tax Expense	$8M	$26M	$12M	$17M	$20M
Net Income	$78M	$90M	$73M	$192M	$75M
Net Margin	7.3%	6.2%	5.0%	14.9%	5.9%
EPS (Diluted)	$1.32	$1.51	$1.22	$3.24	$1.29
EBITDA	$140M	$194M	$198M	$172M	$202M
Shares Outstanding	59M	60M	60M	59M	58M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$770M	$738M	$706M	$637M	$651M	$646M	$622M	$631M
Cost of Revenue	$602M	$566M	$525M	$481M	$492M	$470M	$467M	$477M
Gross Profit	$169M	$172M	$180M	$156M	$159M	$175M	$155M	$154M
Gross Margin	21.9%	23.3%	25.6%	24.5%	24.4%	27.1%	25.0%	24.5%
R&D Expenses	$24M	$24M	$22M	$25M	$23M	$22M	$21M	$23M
SG&A Expenses	$91M	$93M	$86M	$91M	$92M	$90M	$81M	$86M
Operating Expenses	$115M	$117M	$113M	$123M	$115M	$112M	$102M	$112M
Operating Income	$54M	$55M	$51M	$34M	$44M	$64M	$53M	$42M
Operating Margin	7.0%	7.4%	7.2%	5.3%	6.7%	9.8%	8.5%	6.7%
Interest Expense	$11M	$13M	$22M	$9M	$13M	$13M	$9M	$10M
Income Before Tax	$45M	$43M	$23M	$30M	$33M	$52M	$43M	$37M
Tax Expense	$8M	$11M	-$5M	$7M	$9M	$9M	$11M	$7M
Net Income	$38M	$28M	$45M	$28M	$26M	$42M	$32M	$30M
Net Margin	5.0%	3.8%	6.3%	4.5%	4.0%	6.6%	5.2%	4.7%
EPS (Diluted)	$0.64	$0.47	$0.75	$0.49	$0.45	$0.72	$0.56	$0.51
EBITDA	$96M	$97M	$112M	$85M	$92M	$107M	$96M	$89M
Shares Outstanding	59M	60M	60M	59M	58M	59M	58M	58M

CRBN.AS AMS